Lixisenatide (Adlyxin) for Type 2 Diabetes Mellitus
Gespeichert in:
| Veröffentlicht in: | American family physician 2017-08, Vol.96 (4), p.257-258 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 258 |
|---|---|
| container_issue | 4 |
| container_start_page | 257 |
| container_title | American family physician |
| container_volume | 96 |
| creator | Niedermier, Valerie Ayers, Gina Springer, Sydney |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1940592313</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1940592313</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-daf2f3ed55d8c76ba31735b02f1b29bae136df5ffdfcaa264bef31ff01a453c43</originalsourceid><addsrcrecordid>eNo1j8tqwzAQRUWhNGnSXyhapguDpLFkexnSJ7h0k6yNZM2Ail-1bIj_voGmq7M5HO69YWupQSXCaLFi9zF-CyEyLYs7tlJ5obQx-ZpBGc4hYmen4JHv9r5ZzqF74tSP_LgMyBV_DtbhhJF_YtOEaY5bdku2ifhw5YadXl-Oh_ek_Hr7OOzLZFBSTom3pAjQa-3zOjPOgsxAO6FIOlU4ixKMJ03kqbZWmdQhgSQS0qYa6hQ2bPfXHcb-Z8Y4VW2I9WWE7bCfYyWLVOhCgYSL-nhVZ9eir4YxtHZcqv-j8As6sk2c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1940592313</pqid></control><display><type>article</type><title>Lixisenatide (Adlyxin) for Type 2 Diabetes Mellitus</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Niedermier, Valerie ; Ayers, Gina ; Springer, Sydney</creator><creatorcontrib>Niedermier, Valerie ; Ayers, Gina ; Springer, Sydney</creatorcontrib><identifier>EISSN: 1532-0650</identifier><identifier>PMID: 28925668</identifier><language>eng</language><publisher>United States</publisher><subject>Blood Glucose - drug effects ; Diabetes Mellitus, Type 2 - drug therapy ; Humans ; Hypoglycemic Agents - adverse effects ; Hypoglycemic Agents - therapeutic use ; Peptides - adverse effects ; Peptides - therapeutic use</subject><ispartof>American family physician, 2017-08, Vol.96 (4), p.257-258</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28925668$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Niedermier, Valerie</creatorcontrib><creatorcontrib>Ayers, Gina</creatorcontrib><creatorcontrib>Springer, Sydney</creatorcontrib><title>Lixisenatide (Adlyxin) for Type 2 Diabetes Mellitus</title><title>American family physician</title><addtitle>Am Fam Physician</addtitle><subject>Blood Glucose - drug effects</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Humans</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Peptides - adverse effects</subject><subject>Peptides - therapeutic use</subject><issn>1532-0650</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j8tqwzAQRUWhNGnSXyhapguDpLFkexnSJ7h0k6yNZM2Ail-1bIj_voGmq7M5HO69YWupQSXCaLFi9zF-CyEyLYs7tlJ5obQx-ZpBGc4hYmen4JHv9r5ZzqF74tSP_LgMyBV_DtbhhJF_YtOEaY5bdku2ifhw5YadXl-Oh_ek_Hr7OOzLZFBSTom3pAjQa-3zOjPOgsxAO6FIOlU4ixKMJ03kqbZWmdQhgSQS0qYa6hQ2bPfXHcb-Z8Y4VW2I9WWE7bCfYyWLVOhCgYSL-nhVZ9eir4YxtHZcqv-j8As6sk2c</recordid><startdate>20170815</startdate><enddate>20170815</enddate><creator>Niedermier, Valerie</creator><creator>Ayers, Gina</creator><creator>Springer, Sydney</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20170815</creationdate><title>Lixisenatide (Adlyxin) for Type 2 Diabetes Mellitus</title><author>Niedermier, Valerie ; Ayers, Gina ; Springer, Sydney</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-daf2f3ed55d8c76ba31735b02f1b29bae136df5ffdfcaa264bef31ff01a453c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Blood Glucose - drug effects</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Humans</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Peptides - adverse effects</topic><topic>Peptides - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Niedermier, Valerie</creatorcontrib><creatorcontrib>Ayers, Gina</creatorcontrib><creatorcontrib>Springer, Sydney</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>American family physician</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niedermier, Valerie</au><au>Ayers, Gina</au><au>Springer, Sydney</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lixisenatide (Adlyxin) for Type 2 Diabetes Mellitus</atitle><jtitle>American family physician</jtitle><addtitle>Am Fam Physician</addtitle><date>2017-08-15</date><risdate>2017</risdate><volume>96</volume><issue>4</issue><spage>257</spage><epage>258</epage><pages>257-258</pages><eissn>1532-0650</eissn><cop>United States</cop><pmid>28925668</pmid><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 1532-0650 |
| ispartof | American family physician, 2017-08, Vol.96 (4), p.257-258 |
| issn | 1532-0650 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1940592313 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Blood Glucose - drug effects Diabetes Mellitus, Type 2 - drug therapy Humans Hypoglycemic Agents - adverse effects Hypoglycemic Agents - therapeutic use Peptides - adverse effects Peptides - therapeutic use |
| title | Lixisenatide (Adlyxin) for Type 2 Diabetes Mellitus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T21%3A15%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lixisenatide%20(Adlyxin)%20for%20Type%202%20Diabetes%20Mellitus&rft.jtitle=American%20family%20physician&rft.au=Niedermier,%20Valerie&rft.date=2017-08-15&rft.volume=96&rft.issue=4&rft.spage=257&rft.epage=258&rft.pages=257-258&rft.eissn=1532-0650&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1940592313%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1940592313&rft_id=info:pmid/28925668&rfr_iscdi=true |